PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
IDEXX Laboratories, Inc. (IDXX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS45168D1046
CUSIP45168D104
SectorHealthcare
IndustryDiagnostics & Research

Highlights

Market Cap$39.56B
EPS$10.05
PE Ratio47.40
PEG Ratio4.75
Revenue (TTM)$3.66B
Gross Profit (TTM)$2.00B
EBITDA (TTM)$1.21B
Year Range$372.50 - $583.39
Target Price$604.62
Short %2.71%
Short Ratio4.54

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


IDEXX Laboratories, Inc.

Popular comparisons: IDXX vs. ZTS, IDXX vs. EXAS, IDXX vs. VOO, IDXX vs. DXCM, IDXX vs. DHR, IDXX vs. EME, IDXX vs. VGT, IDXX vs. COST, IDXX vs. GOOGL, IDXX vs. AAPL

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in IDEXX Laboratories, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%NovemberDecember2024FebruaryMarchApril
11.33%
17.96%
IDXX (IDEXX Laboratories, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

IDEXX Laboratories, Inc. had a return of -13.60% year-to-date (YTD) and -3.24% in the last 12 months. Over the past 10 years, IDEXX Laboratories, Inc. had an annualized return of 22.78%, outperforming the S&P 500 benchmark which had an annualized return of 10.55%.


PeriodReturnBenchmark
Year-To-Date-13.60%6.30%
1 month-9.64%-3.13%
6 months12.12%19.37%
1 year-3.24%22.56%
5 years (annualized)16.43%11.65%
10 years (annualized)22.78%10.55%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-7.20%11.68%-6.14%
2023-14.50%-8.64%16.61%19.16%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of IDXX is 44, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of IDXX is 4444
IDEXX Laboratories, Inc.(IDXX)
The Sharpe Ratio Rank of IDXX is 4747Sharpe Ratio Rank
The Sortino Ratio Rank of IDXX is 4040Sortino Ratio Rank
The Omega Ratio Rank of IDXX is 4040Omega Ratio Rank
The Calmar Ratio Rank of IDXX is 4747Calmar Ratio Rank
The Martin Ratio Rank of IDXX is 4646Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for IDEXX Laboratories, Inc. (IDXX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


IDXX
Sharpe ratio
The chart of Sharpe ratio for IDXX, currently valued at -0.08, compared to the broader market-2.00-1.000.001.002.003.00-0.08
Sortino ratio
The chart of Sortino ratio for IDXX, currently valued at 0.10, compared to the broader market-4.00-2.000.002.004.006.000.10
Omega ratio
The chart of Omega ratio for IDXX, currently valued at 1.01, compared to the broader market0.501.001.501.01
Calmar ratio
The chart of Calmar ratio for IDXX, currently valued at -0.05, compared to the broader market0.001.002.003.004.005.00-0.05
Martin ratio
The chart of Martin ratio for IDXX, currently valued at -0.19, compared to the broader market0.0010.0020.0030.00-0.19
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.92, compared to the broader market-2.00-1.000.001.002.003.001.92
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.78, compared to the broader market-4.00-2.000.002.004.006.002.78
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.33, compared to the broader market0.501.001.501.33
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.47, compared to the broader market0.001.002.003.004.005.001.47
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.64, compared to the broader market0.0010.0020.0030.007.64

Sharpe Ratio

The current IDEXX Laboratories, Inc. Sharpe ratio is -0.08. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00NovemberDecember2024FebruaryMarchApril
-0.08
1.81
IDXX (IDEXX Laboratories, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


IDEXX Laboratories, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2024FebruaryMarchApril
-32.05%
-4.64%
IDXX (IDEXX Laboratories, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the IDEXX Laboratories, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the IDEXX Laboratories, Inc. was 81.46%, occurring on Apr 18, 1997. Recovery took 1735 trading sessions.

The current IDEXX Laboratories, Inc. drawdown is 32.05%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.46%Feb 6, 1996304Apr 18, 19971735Mar 12, 20042039
-57.27%Nov 16, 2007256Nov 20, 2008356Apr 23, 2010612
-54%Aug 6, 2021301Oct 14, 2022
-37.13%Feb 20, 202023Mar 23, 202032May 7, 202055
-35.36%Nov 11, 1991116Apr 27, 1992142Nov 16, 1992258

Volatility

Volatility Chart

The current IDEXX Laboratories, Inc. volatility is 5.20%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%NovemberDecember2024FebruaryMarchApril
5.20%
3.30%
IDXX (IDEXX Laboratories, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of IDEXX Laboratories, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items